Peroxisome proliferator-activated receptor-γ agonist 15-deoxy-Δ12,14-prostaglandin J2 ameliorates experimental autoimmune encephalomyelitis

Journal of Immunology

Volumn 168, Issue 5, 2002, Pages 2508-2515

  Diab, Asim ^a   Deng, Caishu ^a   Smith, Jeff D ^a   Hussain, Rehana Z ^a   Phanavanh, Bounleut ^a   Lovett Racke, Amy E ^a   Drew, Paul D ^a   Racke, Michael K ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; ANTIGEN; CD40 ANTIGEN; CELL NUCLEUS RECEPTOR; CONCANAVALIN A; GAMMA INTERFERON; HORMONE RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 4; LIGAND; MYELIN BASIC PROTEIN; MYELIN BASIC PROTEIN [1-11]; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; INFLAMMATORY INFILTRATE; LYMPHOCYTE CULTURE; LYMPHOCYTE PROLIFERATION; MICROGLIA; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINAL CORD; SPLEEN; T LYMPHOCYTE; TRANSGENIC MOUSE; TREATMENT OUTCOME;

EID: 0036499074     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.5.2508     Document Type: Article

References (39)

1. Immunological aspects of experimental allerigic encephalomyelitis and multiple sclerosis
2. Biotechnical agents for the immunotherapy of multiple sclerosis: Principles, problems and perspectives
3. Animal models of human disease: Experimental autoimmune encephalomyelitis in rodents as a model for human demyelinating disease
4. The nuclear receptor superfamily: The second decade
5. Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors
6. Peroxisome proliferator-activated receptors: A nuclear receptor signaling pathway in lipid physiology
7. Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver
8. mPPAR-γ2: Tissue specific regulator of an adipocyte enhancer
9. Stimulation of adipogenesis in fibroblast by PPAR-γ2, a lipid-activated transcription factor
10. PPAR-γ agonists inhibit production of monocytes inflammatory cytokines
11. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
12. Isolation of the human peroxisome proliferator-activated receptor γ cDNA: Expression in hematopoietic cells and chromosomal mapping
13. The nuclear eicosanoid receptor, PPAR-γ, is aberrantly expressed in colonic cancers
14. The nuclear receptor PPAR-γ and immunoregulation: PPAR-γ mediate inhibition of Th cell responses
15. Peroxisome proliferator-activated receptor γ activators gene expression and migration in human vascular smooth muscle cells
16. PPAR-γ activation in human endothelial cells increases plasminogen activator inhibitor type-1 expression: PPAR-γ as a potential mediator in vascular disease
17. Differentiation and reversal of malignant changes in colon cancer through PPAR-γ
18. Ligand for peroxisome proliferator-activated receptors-γ (troglitazone) has potent anti-tumor effect against human prostate cancer in vitro and in vivo
19. Ligands for peroxisome proliferator-activated receptors-γ and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice
20. Activation of peroxisome proliferator-activated receptors α and γ induces apoptosis of human monocyte-derived macrophages
21. PPAR-γ induces cell cycle withdrawal: Inhibition of E2/DP DNA binding activity via down-regulation of PP2A
22. 2
23. 2 induce synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats
24. A novel therapy for colitis utilizing PPAR-γ ligands to inhibit the epithelial inflammatory response
25. Expression of the peroxisome proliferator-activated receptor γ in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein
26. Inducible cyclooxygenase may have anti-inflammatory properties
27. The role of CTLA-4 in tolerance induction and T cell differentiation in experimental autoimmune encephalomyelitis: i.p. antigen administration
28. Effect of IL-12 on in vivo cytokine gene expression and Ig isotype selection
29. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease
30. The role of costimulation in autoimmune demyelination
31. Mechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosis
32. 2 in activated murine macrophages
33. Anti-inflammatory cyclopentone prostaglandins are direct inhibitors of IκB kinase
34. Amelioration of experimental autoimmune encephalomyelitis in C57BL/6 mice by an agonist of peroxisome proliferator-activated receptor-γ
35. 12,14 prostaglandin J2 represses nitric oxide, TNF-α, and Il-12 production by microglial cells
36. Peroxisome proliferator-activated receptor-γ activators inhibit IFN-γ-induced expression of the T cell-active CXC chemokines 1P-10, Mig, and I-TAC in human endothelial cells
37. Discrete roles for peroxisome proliferator-activated receptor γ and retinoid X receptor in recruiting nuclear receptor coactivators
38. Inducible nitric oxide synthase activity of cloned murine microglial cells
39. Characterization of a novel brain-derived microglial cell line isolated from neonatal rat brain